Last reviewed · How we verify

NCT04727801

A Clinical Data Collection Study of Verily Patch

Terminated Last updated 20 August 2021
What this trial tests

trial testing Verily Patch in Febrile in 22 participants. Terminated before completion.

Timeline
11 March 2021
Primary endpoint
25 May 2021
25 May 2021

Quick facts

Lead sponsorVerily Life Sciences LLC
StatusTerminated
Study typeOBSERVATIONAL
Enrollment22
Start date11 March 2021
Primary completion25 May 2021
Estimated completion25 May 2021
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Verily Life Sciences LLC — full company profile →

Who can join

18 and older, any sex, with Febrile or Afebrile. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a single center, prospective, non-randomized prospective observational data collection study of the Verily Patch. The Verily Patch is an investigational wearable, continuous temperature sensor which will be evaluated against reference oral and axillary temperature measurements to support development activities for the Verily Patch.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Febrile

Currently open trials in the same condition.

Other Verily Life Sciences LLC trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04727801.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing